Prognostic impact of FLT3-ITD load in NPM1 mutated acute
myeloid leukemia. Leukemia.
Fluorescence in situ hybridization characterization of different cryptic BCR/ABL rearrangements in chronic
myeloid leukemia. Cancer Genet and Cytogenet 2004; 155: 132-7.
Diagnosis and management of acute
myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.
In the past six months, his work reported in several publications has led not only to increased understanding of these tenacious cells, but to treatments that may change the standard of care for acute
myeloid leukemia and perhaps other cancers as well.
In chronic
myeloid leukemia patients treated with Imatinib (or other tyrosine kinase inhibitors) documentation of side effects of therapy from the patients' perspective is useful to evaluate efficacy of treatment and overall clinical benefits of newer treatment options.
The patient was diagnosed as having acute
myeloid leukemia (AML).
A 12-year-old male with a history of chronic
myeloid leukemia presented to our dermatology clinic with new-onset hypopigmented patches that are slowly progressive and of varying sizes of six months' duration on his upper limbs, upper chest, and both knees (Figure 1).
Acute
Myeloid Leukemia: Clinical Spectrum of 125 Patients.
Conclusion: Acute
Myeloid Leukemia was the most common malignant hematological disorder followed by Acute Lymphocytic Leukemia.